Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

142 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

NCT06881992

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +29 more
Locations
  • Investigative Site Chicago, Illinois, United States
  • Investigative Site Bethesda, Maryland, United States
  • Investigative Site Boston, Massachusetts, United States
  • Investigative Site Rochester, Minnesota, United States
View all 13 locations
View Trial Details
Recruiting

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

NCT05288205

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Pecking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy Of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tiantan Hospital, Captal Medical University Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

NCT06943755

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +19 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
View all 120 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions
Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations
  • Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
  • Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
  • University of Iowa ( Site 0104) Iowa City, Iowa, United States
View all 84 locations
View Trial Details

Related conditions